Expression of the human Cathepsin L inhibitor hurpin in mice: Skin alterations and increased carcinogenesis

Experimental Dermatology

Volumn 16, Issue 9, 2007, Pages 715-723

  Walz, Markus ^a   Kellermann, Sabine ^a   Bylaite, Matilda ^a,b   Andrée, Birgit ^a   Rüther, Ulrich ^a   Paus, Ralf ^c   Kloepper, Jennifer E ^c   Reifenberger, Julia ^a   Ruzicka, Thomas ^a,d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b VILNIUS UNIVERSITY   (Lithuania)

^c UNIVERSITY OF LÜBECK   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Array analysis; Cathepsin L inhibitor; Hurpin; Skin cancer; Transgenic mice

Indexed keywords

CASPASE 3; CATHEPSIN L; CATHEPSIN L INHIBITOR; CYSTEINE PROTEINASE INHIBITOR; HURPIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; HAIR DISEASE; HUMAN; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SKIN APPENDAGE; SKIN CANCER; SKIN CARCINOGENESIS; SKIN DEFECT; TISSUE SPECIFICITY; TRANSGENIC MOUSE; TUMOR VASCULARIZATION; ULTRAVIOLET RADIATION; WILD TYPE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; CARCINOGENS; CATHEPSINS; CELL TRANSFORMATION, NEOPLASTIC; CYSTEINE ENDOPEPTIDASES; HUMANS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROARRAY ANALYSIS; SERPINS; SKIN; TETRADECANOYLPHORBOL ACETATE; ULTRAVIOLET RAYS;

EID: 34547864989     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2007.00579.x     Document Type: Article

References (42)

1. Nakagawa T, Roth W, Wong P, et al. Cathepsin L: Critical role in Ii degradation and CD4 T cell selection in the thymus. Science 1998: 280: 450-453.
2. Roth W, Deussing J, Botchkarev V A, et al. Cathepsin L deficiency as molecular defect of furless: Hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J 2000: 14: 2075-2086.
3. Tobin D J, Foitzik K, Reinheckel T, et al. The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling. Am J Pathol 2002: 160: 1807-1821.
4. Reinheckel T, Deussig J, Roth W, Peters C. Towards specific functions of lysosomal cysteine peptidases: Phenotype of mice deficient for cathepsin B or cathepsin L. Biol Chem 2001: 382: 735-741.
5. Lombardi G, Burzyn D, Mundinano J, et al. Cathepsin-L influences the expression of extracellular matrix in lymphoid organs and plays a role in the regulation of thymic output and of peripheral T cell number. J Immunol 2005: 174: 7022-7032.
6. Felbor U, Kessler B, Mothes W, et al. Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci U S A 2002: 99: 7883-7888.
7. Stypmann J, Glaser K, Roth W, et al. Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L. Proc Natl Acad Sci U S A 2002: 99: 6234-6239.
8. Spring P, Nakashima T, Frederick M, Henderson Y, Clayman G. Identification and cDNA cloning of headpin, a novel differentially expressed serpin that maps to chromosome 18q. Biochem Biophys Res Commun 1999: 264: 299-304.
9. Zou Z, Anisowicz A, Hendrix M J, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994: 263: 526-529.
10. Turk V, Bode W. Human cysteine proteinases and their inhibitors, stefins and cystatins. In: Aviles F X, ed. Innovations in Proteases and Their Inhibitors. Berlin: Walter de Gruyter, 1993: 47-59.
11. Bevec T, Stoka V, Pungercic G, Dolenc I, Turk V. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J Exp Med 1996: 183: 1331-1338.
12. Welss T, Sun J, Irving J A, et al. Hurpin is a selective inhibitor of lysosomal cathepsin L and protects keratinocytes from ultraviolet-induced apoptosis. Biochemistry 2003: 42: 7381-7389.
13. Jayakumar A, Kang Y, Frederick M J, et al. Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): A kinetic analysis. Arch Biochem Biophys 2003: 409: 367-374.
14. Moussali H, Bylaite M, Welss T, Abts H F, Ruzicka T, Walz M. Expression of hurpin, a serine proteinase inhibitor, in normal and pathological skin: Overexpression and redistribution in psoriasis and cutaneous carcinomas. Exp Dermatol 2005: 14: 420-428.
15. Bylaite M, Moussali H, Marciukaitiene I, Ruzicka T, Walz M. Expression of cathepsin L and its inhibitor hurpin in inflammatory and neoplastic skin diseases. Exp Dermatol 2006: 15: 110-118.
16. Abts H F, Welss T, Scheuring S, et al. Sequence, organization, chromosomal localization, and alternative splicing of the human serine protease inhibitor gene hurpin (PI13) which is upregulated in psoriasis. DNA Cell Biol 2001: 20: 123-131.
17. Paus R, Muller-Rover S, Van Der Veen C, et al. A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol 1999: 113: 523-532.
18. Rousselet N, Mills L, Jean D, Tellez C, Bar-Eli M, Frade R. Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment. Cancer Res 2004: 64: 146-151.
19. Yuspa S H. Overview of carcinogenesis: Past, present and future. Carcinogenesis 2000: 21: 341-344.
20. Hennings H, Glick A B, Lowry D T, et al. FVB/N mice: An inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 1993: 14: 2353-2358.
21. DiGiovanni J, Imamoto A, Naito M, et al. Further genetic analyses of skin tumor promoter susceptibility using inbred and recombinant inbred mice. Carcinogenesis 1992: 13: 525-531.
22. Millar S E. Molecular mechanisms regulating hair follicle development. J Invest Dermatol 2002: 118: 216-225.
23. Petermann I, Mayer C, Stypmann J, et al. Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice. FASEB J 2006: 20: 1266-1268.
24. Abts H F, Welss T, Mirmohammadsadegh A R, Köhrer K, Michel G, Ruzicka T. Cloning and characterization of hurpin (protease inhibitor 13): A new skin-specific, UV-repressible serine proteinase inhibitor of the ovalbumin serpin family. J Mol Biol 1999: 293: 29-39.
25. Leist M, Jaattela M. Triggering of apoptosis by cathepsins. Cell Death Differ 2001: 8: 324-326.
26. Guicciardi M E, Leist M, Gores G J. Lysosomes in cell death. Oncogene 2004: 23: 2881-2890.
27. Stoka V, Turk B, Turk V. Lysosomal cysteine proteases: Structural features and their role in apoptosis. IUBMB Life 2005: 57: 347-353.
28. Ishisaka R, Utsumi T, Yabuki M, et al. Activation of caspase-3-like protease by digitonin-treated lysosomes. FEBS Lett 1998: 435: 233-236.
29. Stoka V, Turk B, Schendel S L, et al. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem 2001: 276: 3149-3157.
30. Levicar N, Dewey R A, Daley E, et al. Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis. Cancer Gene Ther 2003: 10: 141-151.
31. Takeda A, Kajiya A, Iwasawa A, Nakamura Y, Hibino T. Aberrant expression of serpin squamous cell carcinoma antigen 2 in human tumor tissues and cell lines: Evidence of protection from tumor necrosis factor-mediated apoptosis. Biol Chem 2002: 383: 1231-1236.
32. 2-terminal kinase. J Cell Biol 2006: 172: 983-990.
33. Decock J, Paridaens R, Cufer T. Proteases and metastasis: Clinical relevance nowadays? Curr Opin Oncol 2005: 17: 545-550.
34. Chang C, Werb Z. The many faces of metalloproteases: Cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 2001: 11: S37-S43.
35. List K, Haudenschild C C, Szabo R, et al. Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 2002: 21: 3765-3779.
36. Badola S, Spurling H, Robison K, et al. Correlation of serpin-protease expression by comparative analysis of real-time PCR profiling data. Genomics 2006: 88: 173-184.
37. Zhou H M, Bolon I, Nichols A, Wohlwend A, Vassalli J D. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice. Cancer Res 2001: 61: 970-976.
38. Formisano P, Perruolo G, Libertini S, et al. Raised expression of the antiapoptotic protein ped/pea-15 increases susceptibility to chemically induced skin tumor development. Oncogene 2005: 24: 7012-7021.
39. Nakagawa T Y, Brissette W H, Lira P D, et al. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 1999: 10: 207-217.
40. Tsuji T, Sun Y, Kishimoto K, et al. Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation. Cancer Res 2005: 65: 1352-1360.
41. Shellenberger T D, Mazumdar A, Henderson Y, et al. Headpin: A serpin with endogenous and exogenous suppression of angiogenesis. Cancer Res 2005: 65: 11501-11509.
42. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1995: 1: 27-31.